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Furthermore, L-methionine, which is converted to AdoMet via methionine 
adenosyltransferase (MAT), but not D-methionine, regulated the prolif- 
eration of HSC. MAT2A was dominantly expressed in quiescent HSC, 
while MATlA was in hepatocytes. Oral supplementation of L-cysteine and 
L-methionine attenuated TAA-induced liver fibrosis and reduced the ex- 
pression of proteins for SM a-actin, PDGFRb and TGFbRII and mRNAs 
for collagen al (I) and TGFL-II in the liver tissues. 
Conclusion: Supplementation of sulfur-containig amino acids may be im- 
portant element to regulate the molecular activation, in particular prolifer- 
ation, of HSC. 
I 683 WILSON’S DISEASE: LONG TERM TREATMENT WITH ZINC 
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A retrospective analysis was carried on Wilson disease’s (WD) patients 
in order to describe the effectiveness and safety of therapy with Zinc 
Sulphate. We report our experience on 28 patients with WD over an 11 
year period. The patients were followed at Padova Gastroenterology Unit. 
19 males (67.9%). 53.6% with liver disease; 1 case of FHF; 39% with 
neuro/psychiatric disease; 13% diagnosed on the basis of the family his- 
tory. Average age at presentation is 15.5 years (range 4-35): 13 years for 
hepatic presentation, 19 for neurologic one. We considered 2 treatment 
groups: 1) Zn as initial therapy: 10 patients. 70% improved; in 30% wors- 
ening: 2 cases with hepatic and neuropsychiatric involvement, added to 
non-compliance and HCV positivity in one case and one hepatic case with 
eight year delay diagnosis. All these patients underwent OLT. 2) DPCA 
as initial therapy in 18 patients: 35.2% of patients developed DPCA side 
effects, that disappeared with Zn; 28% cases of failure of improvement 
with DPCA (50% hepatic, 50% neurologic): with Zn therapy all were in 
improved conditions, but one hepato-neurologic case, who worsened until 
death; 21% patients switched from DPCA to less side effects Zn, but with 
any intolerance to DPCA; 11.6% on DPCA from the beginning improved 
and showed stable clinical conditions during a period of 1 and 9 years. 1 
FHF after withdraw1 of DPCA. Zn is safe and effective. DPCA is effective 
but its side effect may be severe. OLT is the end stage of treatment and it’s 
effective. 
I 684 NONALCOHOLIC-STEATOHEPATITIS (NASH) AND HEPATIC 
MITOCHONDRIAL BETA-OXIDATION. 
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Background: Experimental data and studies with invasive methods suggest 
an increase of mitochondrial beta-oxidation as a som-ce of oxidative stress 
in Nonalcoholic Steatohepatitis (NASH). 
Aims & Methods: To evaluate the possibility of breath test with sodium- 
13Coctanoate to evaluate medium chain free fatty acid hepatic mito- 
chondrial beta-oxidation. We studied 10 patients (8 male and 2 female; 
BMI 26.17 & 2.40, range 22.05-29.01) with clinical and histological pic- 
tures fully compatible with a diagnosis of NASH and 20 healthy subjects 
matched for age, gender and BMI, as controls. Breath samples were col- 
lect before and every 15 minutes for 2 hours after ingestion of 100 mg 
of water-dissolved octanoic acid-1-13C, sodium salt, 99% atom isoemich- 
ment (Isotec Inc., Miamisburg, OH). 13CO2 enrichment in breath was 
analyzed by isotope ratio/mass spectrometry (Breathmat, Finnigan, USA). 
Results were expressed as cumulative percentage dose of 13CO2 recovered 
at 120 minutes (%13C-OCT). 
Results (mean&SD): 
BMI 
%13C=OCXT(120 min) 
ALT (UIIL) 
AST (UIIL) 
@t 
NASH 
26.17&2.40 
33.66&4.67 
69.X&44.02 
39.16&6.4 
103&78.4 
Healthy 
24.1&0.7 
26.50&3.17 
46& 19.7 
29.5S.l 
x3*54.5 
P 
n.s. 
<0.05 
n.s. 
n.s. 
n.s. 
Conclusion: Our results confirm, “in viva”, the enhanced beta-oxidation in 
the hepatocytes observed in vitro, pointing out the sodium 13Coctanoate 
breath test as a non-invasive tool for the in viva assessment of liver beta- 
oxidation pathway. 
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Background and Aims: The amount and type of dietary carbohydrate and 
fat may affect insulin sensitivity and hepatic disease in different conditions. 
Detailed data on alimentary habits of patients with NASH are sparse. We 
investigated the relation of diet to insulin sensitivity and liver disease in 
patients with non-alcoholic steatohepatitis (NASH) without type 2 diabetes, 
obesity or hyperlipidemia. 
Methods: Twenty-five NASH patients (24 males, age 37 &9 yr, BMI 25.6 
& 2.5 kglm2) (mean & SD) and 25 age-, BMI- and gender-matched healthy 
controls completed a 7-day daily alimentary record (data analyzed by the 
WinFood database) and an oral glucose tolerance test (OGTT). The whole 
body insulin sensitivity index (ISI) was calculated from the OGTT. 
Results: Compared to controls NASH patients consumed more saturated 
fat (SFA: 13.7&3.1 vs. 10.0&2.1% kcal, p=O.OOO), total fat (39.1&4.8 vs. 
31.1&5.2% kcal, p=O.OOO) and cholesterol (506&108 vs. 405&111 mg, 
p=O.O02) and consumed less polyunsaturated fat (10.0&3.5 vs. 14.5&4.0% 
total fat, p=O.OOO), antioxidant C (84.3&43.1 vs. 144.2&63.1 mg, p=O.OOO) 
and E vitamin (5.4&1.9 vs. 8.7&2.9 mg, p=O.OOO). The IS1 was signifi- 
cantly lower in NASH patients than in controls (3.38&1.61 vs. 7.07&1.50; 
p=O.OOO) and correlated with total energy intake (rs=-0.51; p=O.O13) SFA 
(rs=-0.57) but not with BMI or waist circumference. ALT levels correlated 
with IS1 (rs=-0, 49), total energy intake (rs=O, 58) SFA (rs=O, 58) and 
dietary polyunsaturated-to-saturated fat ratio (rs=-0.50). 
Conclusions: In conclusion, our NASH patients consume a diet richer in 
SFA and poorer in polyunsaturated fat and antioxidant C and E vitamin; 
the causal role of these dietary habits and the benefit of their correction 
need to be further assessed. 
I 686 CASPASES, S-ADENOSYL METHIONINE AND ANTI-TUMOR 
NECROSIS FACTOR ALPHA SIGNALING FOR PROTECTION 
IN ETHANOL INDUCED APOPTOSIS IN NORMAL HUMAN 
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Ethanol (EtOH) induces apoptosis in liver cells. 
Aims: l-To assess the mechanism by which EtOH is signaling for apopto- 
sis in normal human primary hepatocytes (NHPH). ~-TO delineate the role 
of tumor necrosis factor alpha (TNFa) antibody (anti-TNFa), caspase- 
9 (CAPI9), caspase-3 (CAP13) inhibitors and S-adenosyl-methionine 
(SAMe) in cell protection against apoptosis. 
Methods: NHPH were treated for 24 hours, either with 80 mM EtOH or 
30 pg/mL TNFa. Apoptosis was assessed by ELISA, and by transmission 
electron microscopy. In a second set of experiments, prior to the same 
